Uterine Leiomyosarcoma Mimicking Benign Submucosal Leiomyoma PATRICIA A. REIF, RDMS
Uterine leiomyosarcoma is a rare, aggressive tumor of the smooth muscle with a typical intramural location. Patients present with abnormal uterine bleeding and an enlarged pelvic mass with clinical signs and symptoms that are virtually indistinguishable from benign leiomyoma. Sonographically, leiomyosarcoma presents as a large solitary tumor that closely resembles a benign leiomyoma that may be undergoing degenerative changes. Because of the infiltrative nature of leiomyosarcoma, invasion into the myometrium may be demonstrated. Leiomyosarcoma has a poor prognosis due to local pelvic recurrences and spread to distant sites. This case report demonstrates a fast-growing submucosal leiomyosarcoma with characteristic sonographic echo enhancement and infiltration into the myometrium.
Key words: abnormal uterine bleeding, myometrium, sonography, uterine leiomyosarcoma (EMC) appeared to encircle the mass, although the distal EMC could not distinctly be seen. The fundal myometrium appeared thinned, and the mass had increased acoustic enhancement. An initial diagnosis was made of a submucosal fibroid. Doppler was not available to further evaluate the mass. The patient elected for conservative surgical management and was scheduled for a diagnostic hysteroscopy and possible endometrial ablation. Hysteroscopy with normal saline could not provide adequate visualization of the endometrial canal. Curettage was subsequently performed, which postoperatively revealed benign findings. A total vaginal hysterectomy with bilateral salpingoophorectomy (TVHBSO) was recommended.
A repeat sonogram was ordered to assess the adnexa and the mass prior to the hysterectomy because hysteroscopy was unsuccessful. The mass visualized 7 weeks earlier increased in size to 6.4 × 3.7 × 4.3 cm and demonstrated further myometrial invasion ( Fig. 2 ). At the time of TVHBSO, the gross appearance of the lesion was a benign submucosal leiomyoma, but the pathology evaluation reported a high-grade leiomyosarcoma with a mitotic count of nine per ten high-power fields. The patient was referred to a gynecological oncologist, who advised a surgical staging procedure for removal of lymph nodes and adjuvant therapy. The patient underwent laparoscopic pelvic and aortic lymph node dissection for stage I leiomyosarcoma. Due to the relatively high risk of recurrence and metastasis, aggressive chemotherapy and radiation therapy were recommended.
Discussion
Uterine leiomyosarcoma (LMS) is a rare, fastgrowing malignant tumor of the smooth muscle in perimenopausal and menopausal women in the fifth decade of life. [1] [2] [3] [4] Sonographic diagnosis of LMS is difficult prior to surgery because it is generally indistinguishable from the benign leiomyoma that may be undergoing degenerative changes. [5] [6] [7] Patients with LMS typically present with abnormal uterine bleeding (AUB) and pelvic pain. An enlarged uterus is a common clinical finding. 1, 2 Because it is an aggressive tumor, local pelvic recurrences and metastasis via the bloodstream to distant sites are frequent. Although the lung is a common site of metastasis, other metastatic sites include the abdomen, brain, and bone. [1] [2] [3] [8] [9] [10] LMSs are rare, occurring in 1.3% of all uterine malignancies. 9, 11 In 90% of LMSs, they are the only mass and are usually large, with a mean diameter of 10 cm. One study reported that 25% of these tumors may be less than 5 cm in diameter. 11, 12 LMSs may be located anywhere in the uterus, but most are located intramurally. 3, 12, 13 Their gross appearance is soft, fleshy, necrotic, and hemorrhagic without the whorled appearance of the typical leiomyoma. 12 Microscopically, their borders are infiltrative rather than well circumscribed. 3, 11, 12 An LMS arising from a leiomyoma is rare. 2, 3, 12 Sonographically, LMS presents as a large, rapidly growing heterogeneous uterine mass that closely resembles a leiomyoma undergoing degenerative changes. 5,6 LMS may have more increased acoustic enhancement than most leiomyomas due to increased vascularity and contain areas of liquefaction. 2, 6 Due to its infiltrative nature, there may be myometrial involvement. 3, 10 Doppler has been used to show characteristics of increased tumor vascularity but is not able to differentiate between LMS and leiomyoma. 14, 15 Differential diagnoses of LMS include leiomyoma, adenomyoma, endometrial adenocarcinoma, other uterine sarcoma, or gasterointestinal and bladder cancers. 10, 16 Although endovaginal sonography remains the standard assessment examination, magnetic resonance imaging (MRI) is rapidly growing as an imaging method of choice to demonstrate LMS because of its ability to demonstrate the number, size, exact location, and the extent of degeneration. 7, 17 Although MRI lacks the microscopic ability to differentiate histologically, it may show tissue characterization and infiltrative margins to prompt further investigation. 7 Positron emission tomography-computed tomography (PET-CT) together may assess anatomic and metabolic information of a suspect uterine mass. 18 Treatment of LMS is a total abdominal hysterectomy and bilateral oophorectomy (TAHBSO). 2 LMS has an overall poor prognosis due to local pelvic recurrence and metastatic spread to distant sites. The surgical stage at presentation is the most important predictor of survival. 1, 3 Tumors that have vascular invasion or extrauterine spread have a grave prognosis. Premenopausal women and women with tumors 5 cm or less have a better chance of survival. 1, 3, 11 This case of uterine LMS demonstrates thinning of the myometrium, relatively rapid growth in 7 weeks, and acoustic enhancement that warranted a careful approach for the patient. However, the initial sonographic diagnosis was a submucosal fibroid. Only after TVHBSO was the correct diagnosis of LMS made. This is consistent with previous findings that LMS is rarely diagnosed until after hysterectomy. 3, 4, 15 
Conclusion
Many of the clinical symptoms and sonographic appearances of uterine LMS mimic the benign leiomyoma. Because of the aggressive nature of LMS, local recurrence, and propensity to spread via the bloodstream to distant sites, any fast-growing uterine tumor may warrant further investigation. Although the presumptive diagnosis was a benign submucosal leiomyoma, endovaginal sonography was helpful in this case to prompt the physician to recommend a more aggressive approach for the patient.
